Biopharmaceuticals Startups That Raised Funding in United States

Psilera Inc.

Location: Tampa, Florida, USA

Website: psilera.com

Funding: Closes Oversubscribed $8.8M

Date: 29 days ago

Psilera Inc. is a Tampa-based biopharmaceutical company pioneering next-generation neuroplastogen and psychedelic therapies, advancing its lead candidate PSIL-006 toward first-in-human trials in 2027 to address neurological disorders.

BioCryst Pharmaceuticals

Location: -

Funding: Raised to $28.00

Date: 49 days ago

BioCryst Pharmaceuticals is a biopharmaceutical company specializing in the design and development of oral small-molecule therapies for rare diseases, leveraging structure-based drug design to address conditions such as hereditary angioedema.

Citius Oncology, Inc.

Location: Cranford, New Jersey

Funding: Secures Up to $36.5 M

Date: 51 days ago

Citius Oncology is a public biopharmaceutical company based in Cranford, New Jersey, focused on developing and commercializing innovative oncology therapies, including its lead product Lymphir.

Satellos Bioscience

Location: -

Funding: Raised to $11.00

Date: 88 days ago

Satellos Bioscience is a biopharmaceutical company developing therapeutics that target DNA damage tolerance and repair pathways to treat cancer and age-related diseases using its proprietary genome integrity platform.

Ocugen

Location: -

Funding: Raised to $10.00

Date: 93 days ago

Ocugen is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies and therapeutics to treat retinal and other ocular diseases, aiming to restore vision by addressing underlying genetic causes.

NewAmsterdam Pharma

Location: -

Funding: Raised to $48.00

Date: 125 days ago

NewAmsterdam Pharma is a clinical-stage biopharmaceutical company developing novel therapies for endocrine and metabolic disorders such as congenital hyperinsulinism and congenital adrenal hyperplasia.

Immunovant

Location: -

Funding: Raised to $22.00

Date: 166 days ago

Immunovant is a clinical-stage biopharmaceutical company developing targeted therapies for autoimmune diseases by inhibiting the neonatal Fc receptor (FcRn) to reduce pathogenic antibodies.

Nurix Therapeutics

Location: -

Funding: Raised to $30.00

Date: 195 days ago

Nurix Therapeutics is a biopharmaceutical company developing targeted small-molecule therapies that harness the ubiquitin proteasome system to degrade disease-causing proteins in oncology and immunology.

Bristol Myers Squibb Company

Location: -

Funding: Raises Dividend to $0.63

Date: 197 days ago

Bristol Myers Squibb is a global biopharmaceutical company specializing in the research, development, and commercialization of prescription therapies for serious diseases, with a focus on oncology, immunology, and cardiovascular health.

OYE Therapeutics

Location: Crown Point, Indiana, USA

Website: oyetherapeutics.com

Funding: raises $5.6M

Date: 203 days ago

OYE Therapeutics is a biopharmaceutical company developing an intravenous caffeine-based therapy to reverse general anesthesia, sedation, and opioid-induced respiratory depression, currently advancing its lead candidate into clinical trials.

Ensysce Biosciences, Inc.

Location: San Diego, CA

Website: ensysce.com

Funding: Secures $4 M

Date: 221 days ago

Ensysce Biosciences is a clinical-stage biopharmaceutical company developing novel severe pain therapeutics with built-in abuse- and overdose-resistant features, such as PF614, to enhance patient safety while providing effective analgesia.

Adicet Bio

Location: -

Funding: Raised to $9.00

Date: 230 days ago

Adicet Bio is a clinical-stage biopharmaceutical company developing off-the-shelf allogeneic gamma delta T-cell therapies for oncology and other diseases, aiming to deliver scalable, immune cell–based treatments.

Exelixis

Location: -

Funding: Raised to $49.00

Date: 230 days ago

Exelixis is a biopharmaceutical company specializing in the discovery, development, and commercialization of small molecule therapies for the treatment of cancer.

Day One Biopharmaceuticals

Location: -

Funding: Raised to $26.00

Date: 230 days ago

Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company developing targeted small molecule therapies for hematologic malignancies and solid tumors to improve patient outcomes.

Harmony Biosciences

Location: -

Funding: Raised to $39.00

Date: 230 days ago

Harmony Biosciences is a biopharmaceutical company focused on developing and commercializing therapies for sleep and neurological disorders, notably its lead product pitolisant (WAKIX) for treating excessive daytime sleepiness in narcolepsy.

Pelthos Therapeutics Inc.

Location: -

Funding: Raises $18 M

Date: 231 days ago

Pelthos Therapeutics Inc. is a biopharmaceutical company that acquires and commercializes antimicrobial therapies, including Xepi (ozenoxacin) cream for the topical treatment of impetigo caused by Staphylococcus aureus and Streptococcus pyogenes.

Ardelyx

Location: -

Funding: Raised to $10.00

Date: 231 days ago

Ardelyx is a biopharmaceutical company focused on developing and commercializing novel therapies for gastrointestinal and cardiorenal disorders, aiming to address unmet medical needs and improve patient outcomes.

PleoPharma, Inc.

Location: Phoenixville, Pa.

Website: pleopharma.com

Funding: Closes $36 M

Date: 248 days ago

PleoPharma, Inc. is a biopharmaceutical company developing treatments for cannabis-related health issues, advancing its lead asset PP-01 into Phase 3 clinical trials for patients with Cannabis Use Disorder.

Emergent BioSolutions Inc.

Location: Gaithersburg, Maryland, USA

Website: emergentbiosolutions.com

Funding: Secures $29 M

Date: 280 days ago

Emergent BioSolutions Inc. develops, manufactures and supplies medical countermeasures, including vaccines and therapeutics against biological threats such as smallpox, anthrax and botulism, to government and public health agencies worldwide.

Amylyx Pharmaceuticals

Location: -

Funding: Raised to $25.00

Date: 281 days ago

Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). Its lead candidate AMX0035 targets cellular stress pathways to slow disease progression and improve patient outcomes.

Telomir Pharmaceuticals, Inc.

Location: -

Funding: Raise $3 M

Date: 401 days ago

Telomir Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for rare diseases. The company leverages strategic equity financing to advance its drug candidates through clinical development.